- Home
- XFOR vs MYFW Comparison
XFOR vs MYFW Comparison
Compare XFOR & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XFOR | MYFW |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.3M | 312.1M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | XFOR | MYFW |
|---|---|---|
| Price | $4.04 | $30.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $9.00 | ★ $27.00 |
| AVG Volume (30 Days) | ★ 669.6K | 43.8K |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.02 |
| EPS | N/A | ★ 1.20 |
| Revenue | $6,500,000.00 | ★ $96,914,000.00 |
| Revenue This Year | N/A | $20.48 |
| Revenue Next Year | N/A | $9.70 |
| P/E Ratio | ★ N/A | $25.72 |
| Revenue Growth | ★ 150.00 | 7.60 |
| 52 Week Low | $2.80 | $21.31 |
| 52 Week High | $4.83 | $34.36 |
Technical Indicators
Market Signals| Indicator | XFOR | MYFW |
|---|---|---|
| Relative Strength Index (RSI) | 50.77 | 43.13 |
| Support Level | $3.58 | $30.49 |
| Resistance Level | $4.48 | $31.24 |
| Average True Range (ATR) | 0.21 | 0.74 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 35.25 | 31.84 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.